title: Survey of regional health care providers on selection of treatment for bulimia nervosa.
abstract: OBJECTIVE
  To determine which treatments clinicians currently recommend for patients with bulimia nervosa (BN), to find out if they recommended evidence-based treatments, and to assess availability and clinician satisfaction with treatment options.
  
  
  METHODS
  Surveys were sent to 1,263 health care providers in Minnesota, Iowa, and Wisconsin who were likely to encounter patients with BN. These health care providers comprised all primary care clinicians, physician assistants, advanced practice nurses, and all mental health/chemical dependency clinicians (MDs, Clinical Nurse Specialist (CNS), social workers, doctoral and masters-level therapists, and chemical dependency (CD) counselors) affiliated with the Mayo Clinic in Rochester, Minnesota.
  
  
  RESULTS
  Evidence-based treatments for BN are recommended consistently and are generally perceived to be available, at least to practitioners affiliated with a large medical center in the Midwest. Clinician satisfaction with treatment options is modest.
  
  
  CONCLUSIONS
  Clinicians are recommending evidence-based treatments for BN patients and find them to be generally available. Modest satisfaction with available treatments may reflect a realistic understanding of treatment options, which need further development.
authors.affiliation: Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55905, USA. mcalpine.donald@mayo.edu
authors.forename: Donald E
authors.initials: DE
authors.lastname: McAlpine
authors.forename: Karla
authors.initials: K
authors.lastname: Schroder
authors.forename: V Shane
authors.initials: VS
authors.lastname: Pankratz
authors.forename: Megan
authors.initials: M
authors.lastname: Maurer
mesh_terms: D002032:Bulimia / Q000188:drug therapy / Q000628:therapy*; D002755:Choice Behavior; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D019317:Evidence-Based Medicine; D006282:Health Personnel; D006287:Health Planning Guidelines; D006801:Humans; D007398:Interpersonal Relations; D012040:Regional Health Planning; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors